Tag:

Moderna

FDA Limits Access To New COVID-19 Vaccines: Here's What To Know FDA Limits Access To New COVID-19 Vaccines: Here's What To Know
FDA Limits Access To New Covid-19 Vaccines: Here's What To Know As fall approaches, the Food and Drug Administration has authorized updated COVID-19 vaccines from both Pfizer-BioNTech and Moderna, but with access limited to those most at risk for severe illness. On Wednesday, Aug. 27, the FDA approved the 2025-2026 formulas from both companies, each tailored to target the LP.8.1 sublineage — a new offshoot of the JN.1 Omicron variant — aligning the vaccines with the strains currently circulating in the US.  Pfizer-BioNTech’s COMIRNATY LP.8.1 is approved for adults 65 and older, as well as individuals ages 5 to 64 with at least one underlying health…
Moderna Slashing Hundreds Of Jobs As COVID-19 Vaccine Sales Slow Moderna Slashing Hundreds Of Jobs As COVID-19 Vaccine Sales Slow
Moderna Slashing Hundreds Of Jobs As Covid-19 Vaccine Sales Slow Vaccine manufacturer Moderna will lay off hundreds of employees about five years after it rose to prominence during the COVID-19 pandemic. The layoffs make up about 10% of Moderna's global workforce, CEO Stéphane Bancel said in a staff memo on Thursday, July 31. The Cambridge, Massachusetts, biotech firm is trying to cut $1.5 billion in annual operating expenses by 2027. Bancel said the job cuts are a "necessary step forward" for the company. "This decision was not made lightly," he wrote. "It impacts teammates and friends who have dedicated themselves to our mission an…
COVID-19: Here's What New Booster Vaccine's Called, What To Know About It, How To Schedule Shot COVID-19: Here's What New Booster Vaccine's Called, What To Know About It, How To Schedule Shot
Covid-19: Here's What New Booster Vaccine's Called, What To Know About It, How To Schedule Shot Health experts are recommending the use of updated COVID-19 booster vaccines to protect people from the most prevalent subvariants of the virus currently circulating. The newly-approved boosters are officially named "bivalent vaccines" that target the original strain of COVID-19 and what is now the predominant subvariant of Omicron, BA.5., according to a report from the University of Texas MD Anderson Cancer Center with Dr. David Tweardy, the head of the Department of Infectious Diseases. “The updated COVID-19 boosters are formulated to better protect against the most recently circulating C…